| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 1.05% |
| NAV | ₹15.31 (22 Sep 2020) |
|---|---|
| Fund Started | 25 Mar 2015 |
| Fund Size | ₹25 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Reliance Industries Ltd. | Energy | Equity | 9.8% |
| Tube Investments Of India Ltd. | Automobile | Equity | 7.7% |
| Hatsun Agro Products Ltd. | FMCG | Equity | 6.5% |
| Neogen Chemicals Ltd. | Chemicals | Equity | 6.0% |
| HDFC Bank Ltd. | Financial | Equity | 5.4% |
| Larsen & Toubro Ltd. | Construction | Equity | 4.2% |
| Camlin Fine Sciences Ltd. | Chemicals | Equity | 4.0% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 3.8% |
| Elgi Equipments Ltd. | Engineering | Equity | 3.5% |
| Multi Commodity Exchange India | Financial | Equity | 3.5% |
SBI Long Term Advantage Fund Series II Direct Growth is a Equity Mutual Fund Scheme launched by SBI Mutual Fund. This scheme was made available to investors on 25 Mar 2015. Rama Iyer Srinivasan, Nidhi Chawla is the Current Fund Manager of SBI Long Term Advantage Fund Series II Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹25 Cr and the Latest NAV as of 22 Sep 2020 is ₹15.31.
The SBI Long Term Advantage Fund Series II Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500.
The scheme seeks to generate capital appreciation over a period of ten years by investing predominantly in equity and equity-related instruments of companies along with income tax benefit.
Upto Rs. 1.5 lac will be tax free under 80C. Lockin of 3 years. Returns will be taxed at 10%.